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Summary 
Structural specialization of the postsynaptic skeletal 
muscle membrane is in part mediated by the motor 
neuron-induced transcriptional regulation of synaptic 
muscle nuclei. ARIA, a factor that stimulates produc- 
tion of acetylcholine receptors (AChRs), is a candidate 
signaling molecule for such regulation. Here we exam- 
ine the transynaptic inducing potential of this polypep- 
tide factor. ARIA immunoreactivity is detectable at 
synaptic sites in vivo. In vitro, recombinant heregulin 
pl (rHRGpl), the human homolog of ARIA, induces 
expression of the AChR e gene, the subunit most sensi- 
tive to synaptic input. The inducing property of 
rHRGpl is demonstrated most dramatically in primary 
muscle cultures from transgenic mice bearing an ~ pro- 
moter-nuclear lacZ reporter transgene. Transient 
transfection experiments using the Sol 8 muscle cell 
line indicate that sequences that confer respon- 
siveness to ARIA are located within a 150 bp z subunit 
promoter region and are E box-independent. These 
results suggest that ARIA performs a vital role by di- 
recting spatially restricted gene expression at the neu- 
romuscular junction. 
Introduction 
Mutual and complementary inductive interactions between 
the motor neuron and its target muscle fiber are central to the 
development of the neuromuscular synapse. Many proteins 
that facilitate synaptic transmission appear as a result of this 
interaction. One distinguishing feature of this model synapse 
is the extraordinarily dense, nerve-dependent accumulation 
of acetylcholine receptors (AChRs). Found at densities of 
less than 10 per square micron extrasynaptically, AChRs 
are present at concentrations of greater than 10,000 per 
square micron in the postsynaptic membrane (Salpeter 
and Harris, 1983; Salpeter et al., 1988). The postsynaptic 
accumulation of AChRs during neuromuscular develop- 
ment is mediated in large part by transcriptional regulation 
(for a review, see Hall and Sanes, 1993). Initially, AChR 
genes are activated independently of the nerve, as part of 
the myogenic program of differentiation. After innervation, 
expression of the muscle-specific AChR subunit genes in 
addition are regulated bytwo nerve-dependent processes: 
first, nerve-induced electrical activity down-regulates 
AChR gene expression throughout he myofiber; second, 
the motor neuron exerts a positive influence on the muscle 
nuclei lying beneath the synapse, resulting in the localized 
induction of AChR subunit genes in a small subset of syn- 
aptic nuclei within the multinucleate muscle fiber. 
Evidence that synaptic nuclei are transcriptionally dis- 
tinct from extrasynaptic muscle nuclei initially came from 
comparisons of AChR subunit mRNA abundance in syn- 
apse-rich versus synapse-poor egions (Merlie and Sanes, 
1985). The finding that the synaptic region of the muscle 
fiber possesses enriched levels of AChR subunit mRNA, 
along with higher resolution observations using in situ hy- 
bridization and transgenic analyses indicating that AChR 
subunit genes are selectively expressed by muscle nuclei 
lying beneath the synapse, suggests that the motor neuron 
supplies a spatially restricted, transynaptic signal that re- 
sults in the activation of specific genes needed for the 
development of the synaptic apparatus (Fontaine et al., 
1988; Goldman and Staple, 1989; Brenner et al., 1990; 
Klarsfeld et al., 1991; Sanes et al., 1991; Simon et al., 
1992). Regulation of the AChR ~ subunit gene provides 
particularly good evidence for transynaptic induction of 
gene expression. The ~ gene exhibits strict spatial regula- 
tion; whereas the AChR a, 13, y, and 8 subunit genes are 
also regulated by mechanisms that permit expression out- 
side the synaptic region under certain conditions, high 
levels of ~ gene expression occur only at the synapse. 
The ~ gene exhibits temporal regulation as well: during 
postnatal maturation of the synapse, embryonic, y sub- 
unit-containing AChRs (stoichiometry a213yS) are re- 
placed by ~ subunit-containing receptors ((~2~s5; Mishina 
et al., 1986; Gu and Hall, 1988). This postnatal switch 
mirrors the time course of ~ gene expression (Witzemann 
et al., 1989; Martinou and Merlie, 1991). Studies involving 
transgenic mice demonstrate that the properties of both 
temporal and synapse-specific gene regulation are con- 
ferred by sequences within the ~ subunit promoter. The 
nlacZ reporter gene, which directs expression of an Esche- 
richia coli l~-galactosidase targeted to nuclei when placed 
under control of ~ regulatory sequences (transgene 
~-nlacZ), confers postnatal expression of the transgene 
in muscle nuclei directly beneath the motor endplate 
(Sanes et al., 1991; Gundersen et al., 1993). Owing to its 
sensitivity to the presence of the motor neuron, the ~ sub- 
unit gene is an ideal gene to study synapse-specific gene 
regulation. 
AChR-inducing activity (ARIA) is currently a leadingcan- 
didate to be a motor neuron-derived inducer of AChR ex- 
pression. This factor was initially characterized as an activ- 
ity present in chicken brain and spinal cord extracts 
capable of increasing the rate of AChR synthesis in myo- 
tube cultures. Purification of this activity subsequently de- 
fined a 42 kDa glycoprotein (Usdin and Fischbach, 1986). 
ARIA was shown to stimulate the expression of several 
AChR subunit genes, accounting for the observed in- 
crease in AChR synthesis (Harris et al., 1988). The ~ sub- 
unit exhibited the most dramatic effect: in mouse myotube 
cultures treated with ARIA, a subunit mRNA levels were 
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Figure 1. ARIA Is Present at the Neuromuscular Junction 
Cryostat sections from rat skeletal muscle were stained with a polyclonal ntibody against rHRGI31 (a, b, and d) or with nonimmune serum (c) in 
conjunction with rhodamine-labeled (L-bungarotoxin. Cells were xamined under fluorescein optics to view HRG/ARIAI31 staining (a, b, and d) or 
with staining in the absence of primary antibody (c). (a')-(d') indicate the position of synapses by visualization of(~-bungarotoxin staining of the 
same sections under hodamine optics. The section shown i  (d and d') was also stained with'crystal violet. Under hodamine optics, this staining 
defines muscle morphology and indicates the position of myofibers. Bar, 50 p.m (a), 10 ~.m (b and c), 30 ~.m (d). 
induced 7- to 10-fold (Martinou et al., 1991). The cloning 
of the gene encoding ARIA revealed it to be the chicken 
homolog of a mammalian gene encoding a family of pro- 
teins: neu differentiation factor (NDF), heregulin (HRG), 
and the Schwann cell mitogen glial growth factor, all de- 
rived from a single gene (Holmes et aL, 1992; Wen et al., 
1992; Falls et al., 1993; Marchionni et al., 1993). NDF and 
HRG were initially characterized by their ability tct bind 
and stimulate the neu (erbB2 and HER2) receptor tyrosine 
kinase, and were subsequently shown to interact with 
erbB3 and erbB4 (HER3 and HER4, respectively), addi- 
tional members of the epidermal growth factor (EGF) re- 
ceptor family of tyrosine kinases (Plowman et al., 1993b; 
Carraway et al., 1994; Kita et al., 1994; Sliwkowski et al., 
1994; Tzahar et al., 1994). The gene encoding ARIA exhib- 
its a large degree of alternate splicing, resulting in great 
heterogeneity ofpredicted translation products. The name 
neuregulin has been proposed to encompass the gene 
and the diversity of ligands that it encodes (for review, see 
Benbaruch and Yarden, 1994). ARIA belongs to the 151 
subclass of neuregulins. 
Here, in support of the hypothesis that ARIA is a physio- 
logically important mediator of AChR regulation atthe neu- 
romuscular junction, we first demonstrate that ARIA pro- 
tein is present at the motor endplate. To investigate the 
inducing potential of ARIA, we examine the regulation of 
the AChR ~ subunit gene using a recombinant form of 
HRG, the human homolog of ARIA. In addition to activating 
the endogenous s subunit gene, this recombinant 68 
amino acid peptide can exert an inductive effect on the 
subunit promoter: s-nlacZ, a synaptically expressed 
transgene in vivo, is essentially inactive in aneural cell 
culture from transgenic mouse muscle, yet in the presence 
of HRG, this transgene exhibits high levels of expression. 
We find a concordance between DNA sequences confer- 
ring synapse-specific expression in vivo and HRG-specific 
inducibility of the ~ subunit gene in vitro. Transient trans- 
fection experiments performed in a HRG-responsive cell 
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line demonstrate that sequence elements sufficient for 
HRG-dependent signaling are located within 150 bp of the 
subunit transcription start site. Furthermore, cis-acting 
sequences that respond to HRG are separate from E box 
elements, a binding site for transcription factors involved 
in myogenic and activity-dependent gene regulation. In 
demonstrating the inductive potential of recombinant 
HRG/ARIA on the ~ subunit promoter in muscle cell cul- 
ture, we reconstitute one major component of synaptic 
signaling in vitro, and thus provide a model for studying 
transynaptic gene regulation. 
Results 
Detection of ARIA at Synaptic Sites 
To provide evidence for the motor neuron-dependent reg- 
ulation of synapse-specific genes by ARIA, we wished to 
determine whether this factor could indeed be found at 
the neuromuscular junction. A polyclonal antibody raised 
against recombinant HRGI~I was used to stain cross sec- 
tions of adult skeletal muscle, These sections were doubly 
stained with rhodamine-labeled ~-bungarotoxin to detect 
synaptic sites. ARiA-positive regions were found to coin- 
cide with motor endplates (Figure 1). A bacterially ex- 
pressed peptide corresponding to amino acids 177-244 
of recombinant HRGI~I (rHRGI~I~_~) was used to affinity 
purify antibodies directed against this region. When anti- 
body prepared in this manner was used to stain muscle 
sections, similar endplate-specific staining was observed 
(data not shown). Synaptic staining was not observed 
when nonimmune serum was used to stain similar sections 
(Figure lc). Our finding that HRG/ARIA is concentrated 
at the synaptic region of the neuromuscular junction fulfills 
one requirement of a putative transynaptic inducing factor 
and is consistent with the inferred role of HRG/ARIA in 
stimulating synapse-specific gene transcription. 
Recombinant HRGJ~I Stimulates Expression of the 
AChR ~ Subunit Gene 
Sequences corresponding to the bioactive EGF-like do- 
main of H RGI31 (rH RGI~ 117~-2~) were expressed and pu ri- 
fled from E. coil (Holmes et al., 1992). To determine 
whether rHRGJ311~7_2~ possessed ARIA activity, we as- 
sayed ~ subunit mRNA levels in mouse primary muscle 
culture using an RNase protection assay. This analysis 
employed a genomic DNA fragment containing exons 
2-4 of the ~ subunit gene for use as a riboprobe template. 
In the absence of any exogenous factors, the abundance 
of ~ subunit mRNA was very low, as observed previously 
in aneural muscle cultures (Martinou et al., 1991). The 
addition of rHRGI~1~77_2~ to these cultures for 48 hr re- 
sulted in an approximately 9-fold induction of the ~ subunit 
gene (Figure 2A). In contrast, rHRGI3117~_244-treated cul- 
tures caused only a slight increase (1.3-fold) in the expres- 
sion of the "house-keeping" gene elongation factor eEF1 
(Figure 2B). No stimulation of the ~ gene was observed 
when EGF, a structural analog of rHRG[~117~_244, was 
added to the cultures instead. These results show that 
recombinant HRGI~I possesses the AChR c subunit-stim- 
ulating activity that had previously been found in native 
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Figure 2. Induction of AChR ~ mRNA in Primary Muscle Culture by
rHRG~I~7~ 2,A 
Total RNA was isolated from primary muscle cultures treated with 3 
nM rHRGI~1,77_2~, 3 nM EGF, or untreated controls. 
(A) RNase protection of the AChR ~ subunit. A probe synthesized from 
genomic DNA hybridizing to exons 2-4 of the s subunit gene was 
used to assess c subunit message levels in 100 ~.g of total RNA. The 
protected fragment corresponding to exon 3 migrates much faster and 
is not seen in this portion ofthe autoradiogram. The experiment shown 
represents the typical result obtained from four independent RNA prep- 
arations. In some experiments, the abundance of ~ subunit mRNA in 
unstimulated cultures was too low for accurate measurement; thus, the 
magnitude of HRG-dependent s imulation could not be determined. 
In cultures in which quantitation was possible, an 8.9-fold average 
stimulation was found. 
(B) RNase protection of the eEFI~ gene. A probe synthesized from 
a cDNA clone was used to measure mRNA levels in 5 I~g of total RNA. 
Average stimulation was found to be 1.3-fold. 
ARIA preparations, and that this induction demonstrates 
specificity in both the inducing factor as well as the genes 
that are activated. 
In Vitro Activation of a Synapse-Specific Transgene 
The ~3500nlacZ transgene (3.5 kb of the ~ subunit pro- 
moter fused to nlacZ) exhibits spatially restricted expres- 
sion in muscle nuclei beneath the motor endplate (Sanes 
et al., 1991). Expression of this transgene in vivo is thus an 
excellent indicator of synaptic input. We took advantage of 
this property by developing an in vitro assay for the induc- 
tion of synapse-specific gene expression. Muscle cells 
from transgenic mice (line ~29) were dissociated and cul- 
tured. In this procedure, only the mononucleate satellite 
cells are mitotically active and proliferate in culture. These 
cells fuse and differentiate upon reaching confluence and 
when the serum-rich media is replaced with serum-poor 
media. Myotubes from ~3500nlacZ muscle cultured in this 
manner exhibited little expression of the transgene, with 
only an occasional nucleus showing any sign of I~-galac- 
tosidase accumulation (Figure 3a). This result was antici- 
pated, for in the absence of neuronal innervation, the 
subunit gene is not expressed at high levels. 
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Figure 3. Activation of the ~3500nlacZ Transgene in Primary Muscle Culture by rHRGI~11T~_2~ 
Primary muscle cultures were prepared from newborn mice possessing the s3500nlacZ transgene (line ~9). Cultures were stained for ~-galactosidase 
activity after 7 days in culture. (a) Transgenic ulture with no exogenous factors added; (b) 3 day treatment with 3 nM rHRGI~11n-2,,; (c) 3 day treatment 
with 3 nM EGF; (d) High magnification f cells in (b). Bar, 300 pm (a-c), 30 I~m (d). 
Muscle cultures treated with rHRGI311n_2,~ for 72 hr ex- 
hibited a dramatic induction of transgene expression (Fig- 
ures 3b and 3d). Though some myotubes showed no 
transgene activation, intense nlacZ staining was observed 
in nuclei within many myotubes. In a small number of myo- 
tubes, a graded pattern of staining was present, which 
could be due to expression in a subset of nuclei within a 
given myotube with limited cytoplasmic diffusion of nlacZ 
mRNA or protein (Ralston and Hall, 1989). Staining was 
not seen in either mononucleated, unfused myoblasts or 
the non-muscle cells that were present in these cultures. 
Although the majority of cell culture experiments were per- 
formed with cultures from line s29, the activation of the 
s3500nlacZ transgene was also bserved in muscle cul- 
tures from line ~51, an independent transgenic mouse line 
possessing the ~3500nlacZ construct (data not shown). In 
a quantitative solution assay of I~-galactosidase activity, 
transgene xpression in untreated cultures was slight. Ac- 
tivation was readily detected at 100 pM rHRGI31177_2,~ and 
was found to increase over two orders of magnitude of 
concentration (Figure 4). The range of concentrations 
used in our assay is similar to those required to maximally 
phosphorylate p185 erbe2, one of the receptor targets of 
HRG activation (Holmes et al., 1992). We thus find that 
rHRGI~I~7_2,~ can induce the in vitro expression of a 
transgene that in vivo exhibits strict synapse-specific regu- 
lation. This activation in culture occurs at a frequency far 
greater than that observed in innervated muscle, and is 
consistent with the hypothesis that availability of the spe- 
cific nerve-derived signal (i.e., HRG/ARIA) is a limiting fac- 
tor for ~ subunit expression in vivo. 
To demonstrate the specificity of this effect, we as- 
sessed the ability of a series of other compounds to acti- 
vate the a3500nlacZ transgene. Table 1 summarizes these 
results. EGF, a structural homolog of rHRGI~1177_244, failed 
to result in activation (Figure 3c), as did ligands for a variety 
of other receptor tyrosine kinases. A recombinant prepara- 
tion of agrin (Ferns et al., 1993), which has been shown 
to induce the posttranslational clustering of AChR, did not 
result in stimulation of the transgene. Finally, calcitonin 
gene-related peptide and ascorbic acid, two compounds 
that have been shown to increase AChR (z subunit mRNA 
in myotube cultures (Fontaine et al., 1987; Horovitz et al., 
1989), also failed to induce the expression of nlacZ- 
positive nuclei. Thus, of the compounds analyzed, only 
rHRGI}1177_=,~ was found to be capable of substituting for 
the effects of the motor neuron in culture. 
The results obtained above indicate that sequences 
within 3500 bp of the ~ subunit transcriptional start site 
confer HRG inducibility. Recently, ~280nlacZ, a construct 
bearing only 280 bp of regulatory sequences fused to the 
nlacZ reporter, was also shown to direct synapse-specific 
staining when expressed in transgenic mice (Gundersen 
et al., 1993). When muscle cultures were prepared from 
~280nlacZ mice, myotubes treated with rHRGI~ll~-z,~ 
exhibited activation of this transgene. As found for the 
penetrance of expression of this transgene in vivo, the de- 
gree of expression of ~280nlacZ in culture was weaker 
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rHRG~1177_244 concentration (nM) 
Figure 4. Dose-Dependent Effect of rHRG~1177-2,.4on the ~3500nlacZ 
Transgene 
Primary muscle cultures were prepared from transgenic mice or wild- 
type controls from the same genetic background. ~-Galactosidase ac- 
tivity was quantified on day 7, after a 3 day treatment with varying 
concentrations of rHRGI~1~T7_2~4 using an ONPG solution assay. Ac- 
tivity is defined as A420 per milligram of protein per hour assayed. 
Nontransgenic ontrols were assayed in parallel to assess the endoge- 
nous I~-galactosidase contribution to the total enzymatic activity. Each 
point on the transgenic data curve represents the average of 7 wells 
from two independent experiments; controls were performed in qua- 
druplicate. Error bars indicate SEM. 
than that of s3500nlacZ.  To quant i tate the effects of 
rHRGI~I ~77-244 on ~280nlacZ cultures, myotubes  were  visu- 
ally scored for act ivat ion of the t ransgene.  A myotube  was  
cons idered  posit ive if a s ingle nucleus within the myotube  
exhib i ted 13-galactosidase activity. Despi te  the lower levels 
Table 1. Inducing Potential of Various Substances on the 
s3500nlacZ Transgene 
Substance Concentration Activation of Transgene 
Serum-rich media 10% HS/5% NBS - 
EGF 3 nM - 
Heparin 5 p_g/ml - 
Basic FGF 5 nM - 
TTX 5 ~M - 
CGRP 100 nM - 
Ascorbic Acid 30 p,g/ml - 
NGF 50 ng/ml - 
Insulin 10 ~g/ml - 
Agrin 10 ng/ml - 
rHRG~1177_244 3 nM +++ 
Activation of the s3500nlacZ transgene by various compounds was 
assessed in transgenic muscle culture. The compounds listed above 
were added to cultures that had been differentiating in serum-poor 
media for 24 hr. Wells treated with serum-rich medium were not subject 
to this serum switch. Determination of transgene activation was per- 
formed by visually assessing 13-galactosidase accumulation by X-GAL 
staining of cultures 72 hr after treatment, compared with staining in 
untreated controls. HS, horse serum; NBS, newborn calf serum; EGF, 
epidermal growth factor; FGF, fibroblast growth factor; TTX, tetrodo- 
toxin; CGRP, calcitonin gene related peptide; NGF, nerve growth fac- 
tor; rHRG, recombinant heregulin. 
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Figure& rHRG1511~_2,,-Dependent Activation of the a280niacZ 
Transgene 
(A) ONPG solution assay of E35O0nlacZ myotubes cultured in the pres- 
ence or absence of 3 nM rHRG~1177=244. Transgene-independent, en- 
dogenous levels of I?,-galactosidase activity have been subtracted from 
both treatment conditions. Activity is defined as A420 per milligram of 
protein per hour. 
(B) Muscle cultures from ~280nlacZ transgenic mice; 35 mm wells 
were stained with X-GAL and visually scored for transgene activation. 
A myotube was considered positive if a single nucleus within the myo- 
tube exhibited 13-galactosidase activity. Error bars indicate SEM. Each 
condition was performed in triplicate. 
of  express ion ,  the s280nlacZ construct  exhib i ted an in- 
duct ive response  to rHRGI31177-244 similar to that of the 
~3500nlacZ t ransgene (Figure 5). These  results suggest  
that the abil ity of  the ~ subunit  gene  to respond to HRG,  
like its abil ity to respond to the motor  neuron,  is mediated 
by regulatory e lements  in the ~ subunit  promoter .  
Analysis of HRG/ARIA-Dependent Gene Regulation 
in a Muscle Cell Line 
For further  analys is  of the ARIA-mediated  induction of 
gene  express ion,  we turned to Sol 8, a fus ion-competent  
muscle cell l ine der ived f rom the mouse  so leus  muscle 
(Mul le et al., 1988). Sol 8 cells possess  the abil ity to ex- 
press  increased (albeit low) levels of s subu nit: m RNA when 
mainta ined for extended per iods of t ime in culture and can 
generate  funct ional  adult  AChRs  (Pinset et al., 1991). We 
Neuron 
334 
A 
exon 2 
exon 4 
AChR 
B 
i i 
eEFl~z 
Figure 6. Induction of AChR s subunit mRNA in Sol 8 Myotube Cul- 
tures 
(A) RNase protection of the AChR s subunit. A probe synthesized from 
genomic DNA hybridizing to exons 2-4 of the s subu nit gene was used 
to quantitate ~ subunit message abundance in 100 pg of total RNA. 
The protected fragment corresponding to exon 3 migrates much faster 
and is not seen in this portion of the autoradiogram, The faint band 
below exon 2 represents a nonspecific hybridizing artifact and is pres- 
ent when yeast tRNA is present. Four independent Sol 8 RNA prepara- 
tions were analyzed: s subunit stimulation ranged from 11.2- to 15-fold 
(average = 12.6-fold). 
(B) RNase protection of the eEFla gene. A probe synthesized from 
a cDNA clone was used to measure mRNA levels in 5 pg of total RNA. 
The ratio of eEF1 ~ mRNA in HRG-treated versus untreated Sol 8 cells 
was 0.98 (average of four experiments). 
found that, in the absence of rHRGI31177-244, Sol 8 cells did 
indeed exhibit extremely low levels of E subunit mRNA 
(Figure 6A). However, Sol 8 myotube cultures treated with 
rHRGI~1177-244 exhibited on average a 12.6-fold induction 
of the s subunit gene. The eEFI~ gene showed no change 
in response to similar treatment (0.98; n = 4; see Figure 
6B). 
We sought to take advantage of the availability of this 
easily manipulated cell line to characterize further the cis- 
acting region of the s subunit promoter that confers HRG 
inducibility. Plasmid constructs bearing s promoter se- 
quences fused to the bacterial reporter chloramphenicol 
acetyltransferase (CAT) were transiently transfected into 
Sol 8 cultures, rHRGI31177-244 was added to the cultures 24 
hr after induction of differentiation by transfer to low-serum 
media. The CAT reporter gene was used in place of the 
nlacZ reporter to facilitate quantitation and comparison 
with other promoter-CAT constructs. Construct s280- 
CAT, containing regulatory sequences identical to those 
present in the s280nlacZ transgenic mouse, exhibited a 
4-fold stimulation in expression when the cultures were 
treated with rH RGI31177-244. A shorter construct, s150-CAT, 
demonstrated a similar, 6-fold effect (Figure 7). In contrast, 
a plasmid containing sequences from the human cardiac 
alpha actin gene fused to CAT showed no induction in 
response to rHRG~1177_244 (Figure 7). The magnitude of 
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Figure 7. E Box-independent Induction of s-CAT Constructs by 
rHRGI31~_244 inSol 8 Transient Transfection 
Constructs were transiently transfected into Sol 8 myoblasts, At 24 hr 
after the induction ofdifferentiation, 3 nM rHRG~,1177-244 was added to 
the wells. Cells were harvested for analysis 3 days later. A cotrans- 
fected plasmid encoding ~-galactosidase activity was used to normal- 
ize for variations in transfection efficiency among constructs. Each 
plasmid was transfected in duplicate; the data shown represent aver- 
age values from three or four independent transfections. Error bars 
indicate SEM. See text for description of plasmids. 
induction on the ~ subunit promoter seen in these transient 
assays (4- to 6-fold) was found to be somewhat less than 
that observed for endogenous subunit mRNA (9- to 12- 
fold), or for induction of the nlacZ reporter gene in 
transgenic mice. We suggest that transiently transfected 
plasmid constructs exhibit higher levels of basal (unstimu- 
lated) expression as compared with the uninduced expres- 
sion levels observed in genes that have been stably inte- 
grated into chromosomal DNA (as is the case for the 
endogenous subunit gene and the s-nlacZ transgene). 
This effect in transient ransfection may therefore result 
in an apparent HRG-dependent induction which is some- 
what less robust than that observed with integrated genes. 
Nonetheless, these transfection experiments indicate that 
the proximal 150 bp of promoter sequence can confer 
HRG responsiveness to the s subunit gene, and as a result 
establish a cell culture system whereby mechanisms of 
HRG-dependent (and perhaps synapse-specific) gene 
regulation may be elucidated. 
E Box-Independent Mediation of the 
Heregulin Response 
The E box element, defined by the consensus sequence 
CANNTG, is the target binding site for the family of myo- 
genic basic-helix-loop-helix transcription factors MyoD, 
myogenin, MRF4, and myf5. E boxes are present in the 
regulatory regions of all the AChR subunit genes and are 
involved in activation of these genes during the myogenic 
differentiation program (Piette et al., 1990; Prody and Mer- 
lie, 1992; Simon and Burden, 1993). Electrical activity- 
dependent AChR subunit gene regulation by an E box 
element has also been shown for the AChR a and 8 subunit 
genes (Bessereau et al., 1994; Tang et al., 1994). The 
subunit gene contains two E boxes within 280 bp of the 
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transcriptional start site, but deletion analysis indicates 
the distal E box is unnecessary for cell type- and differenti- 
ation-specific expression (Duclert et al., 1993; Sunyer and 
Merlie, 1993). To determine whether E box sequences are 
involved in mediating HRG-dependent signaling, con- 
struct ~150(mutE)-CAT was transfected into Sol 8 cells. 
This plasmid contains a mutation in the remaining, proxi- 
mal E box. In the absence of exogenously added 
rHRG~11~_244, the uninduced level of expression of 
~150(m utE)-CAT was found to be approximately one-tenth 
that of the unmutated construct (Figure 7). However, this 
mutation did not abolish the HRG-induced effect. Although 
the absolute level of induced expression was also reduced 
in this mutant construct, the HRG-dependent magnitude 
of induction was found to be 14-fold, greater than the 6-fold 
induction observed with the wild-type ~150-CAT plasmid. 
The E box may therefore regulate levels of myogenic fac- 
tor-dependent expression, but it is unlikely to be involved 
directly in HRG-induced gene expression. 
Discussion 
Activation of the AChR ~ Subunit Gene 
by Recombinant HRG/ARIA 
Transgenic and in situ hybridization studies have pre- 
viously suggested that the motor neuron supplies a signal 
which induces the synaptic expression of the AChR ~ sub- 
unit gene. In agreement with these observations, we find 
that, in muscle cells cultured in the absence of innervation, 
low levels of endogenous ~ subunit mRNA or reporter gene 
activity from ~-nlacZ transgenic mice can be detected. Of 
the many compounds tested, only HRG can substitute for 
the synaptic signal by inducing the ~ subunit gene in myo- 
tube cultures. Furthermore, we find a correlation between 
promoter sequences involved in synapse-specific gene 
expression in vivo and HRG-induced gene expression in 
vitro. These results, along with our finding that HRG is 
localized at neuromuscular synapses, strongly suggest 
that HRG/ARIA is a physiologically important mediator of 
the motor neu ron-dependent regulation of synaptically ex- 
pressed muscle genes. 
In examining the relationship between HRG and ~ gene 
expression, we have established an in vitro model that may 
be used to study mechanisms of transynaptic induction of 
gene expression. The cell culture model demonstrates the 
following properties: first, recombinant HRG stimulates 
endogenous mRNA levels of the AChR ~ subunit gene, a 
synapse-specific gene. Second, ~ promoter sequences 
that direct the in vivo synaptic expressien of a nlacZ re- 
porter in transgenic mice also respond to induction by 
HRG in primary muscle culture. Third, in transient rans- 
fection of a muscle cell line, HRG can increase expression 
of a CAT reporter construct when placed under the control 
of the ~ proximal promoter. This model may be used to 
understand various processes necessary for synapse- 
specific gene expression, i.e., defining synaptic cis-acting 
sequences and trans-acting DNA binding proteins and elu- 
cidating signaling intermediates. 
We used a recombinant fragment of HRGI31, the human 
homolog of ARIA, as our source of this inducing factor. 
ARIA was initially characterized as a 42 kDa glycoprotein 
(Usdin and Fischbach, 1986), yet we find that the bacteri- 
ally expressed, unglycosylated EGF-like domain of HRGI31 
is sufficient for ARIA activity. This result is consistent with 
studies which show that this EGF-like domain is sufficient 
to activate erbB2, erbB3, and erbB4, putative ARIA recep- 
tors belonging to the class I family of receptor tyrosine 
kinases (Plowman et al., 1993b; Carraway et al., 1994; 
Kita et al., 1994; Sliwkowski et al., 1994; Tzahar et al., 
1994), and that EGF itself does not possess this property 
(Plowman et al., 1993a). 
The ability of H RG to activate the ~3500nlacZ transgene 
in vitro visually underscores the inducing potential of this 
factor. However, it is unclear why some muscle nuclei 
cultured from ~3500nlacZ mice fail to express nlacZ even 
in the presence of rHRGI311~7_2,~. Similar observations 
have been reported by others using in situ analysis of 
chicken myotube cultures; these demonstrated preferen- 
tial activation of the AChR ~ subunit gene in a subset of 
muscle nuclei (Bursztajn et al., 1989; Fontaine and 
Changeux, 1989; Harris et al., 1989). Even in the presence 
of ARIA, only a fraction of muscle nuclei exhibited induc- 
tion of this subunit gene (Harris et al., 1989). Perhaps 
some molecule that mediates ARIA-induced signaling-- 
either a receptor or corequisite factor--is only variably 
present on the surface of cultured myotubes. Molecules 
that are enriched in the synaptic basal lamina of muscle 
fibers may be candidates, since synaptic basal lamina can 
direct synapse-specific gene expression in regenerating 
muscle (Goldman et al., 1991; Brenner et al., 1992; Jo 
and Burden, 1992). Although the active factor in synaptic 
basal lamina is potentially HRG/ARIA itself, other compo- 
nents of lamina may assist in inducing synaptic expres- 
sion. Despite the insensitivity of some nuclei to the effects 
of HRG, we find that the population of nuclei capable of 
expressing the ~ subunit gene in HRG-induced cultures 
is far larger than the subset of nuclei that actually do ex- 
press it in innervated muscle. 
HRG and Synapse-Specific Regulation of the 
Subunit Promoter 
Previously, we showed that sequences within 280 bp of the 
subunit gene could direct synapse-specific expression in 
vivo. In an independent study, Duclert et al. (1993) sug- 
gested that sequences within 83 bp of the gene conferred 
synaptic expression in muscle fibers injected with DNA. 
The localization of HRG-responsive sequences to 150 bp 
of the ~ subunit transcriptional start site indicates that 
these sequences are the same as those required for syn- 
apse-specific expression. Studies examining the potential 
role of the E box in conferring synapse-specific gene ex- 
pression have failed to show any involvement (Duclert et 
al., 1993; Tang et al., 1994); analogously, we provide direct 
evidence that the HRG-dependent activation of the ~ sub- 
unit promoter can occur independently of E box se- 
quences. Expression of the ~ subunit gene may be deter- 
mined by contributions from at least two separate 
mechanisms of gene activation: activation via the execu- 
tion of the myogenic differentiation program as well as 
expression resulting from a HRG-mediated pathway. The 
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apparent magnitude of HRG-inducible gene expression 
in vitro (or synapse-specific induction in vivo) would thus 
depend on the relative contribution of both of these two 
positive influences. In transient transfections of the 
~150(mutE)-CAT construct, elimination of the E box re- 
sults in a reduction of basal levels of expression, but does 
not as adversely affect HRG-induced stimulation of the 
reporter gene. As a result, this construct displays an in- 
creased response to signaling by HRG. 
Postnatal Onset of ~ Subunit Gene Expression 
Although there is strong evidence that HRG plays a vital 
role in synapse-specific gene expression, not all aspects 
of synapse-specific gene regulation are explained by this 
inducing factor. HRG mRNA is detectable in the spinal 
cord as early as embryonic day 9 or 10 during mouse 
development (Marchionni et al., 1993; Meyer and Birch- 
meier, 1994), yet expression of the ~ subunit gene is mini- 
mal until the postnatal period. The delayed onset of ~ sub- 
unit expression may result from an insensitivity of the 
embryonic muscle fiber to the inducing signal. This expla- 
nation is unlikely, however, since synapse-specific gene 
expression can be demonstrated for at least the AChR 7 
subunit during fetal development (G. C. C. and J. P. M., 
unpublished ata). Perhaps efficient ranscription of the 
subunit gene requires synaptic induction acting in concert 
with an additional, as yet unidentified, developmentally 
regulated factor. The myogenic transcription factor MRF4 
may be one possible candidate. MRF4 expression occurs 
relatively late during fetal development, subsequent to 
MyoD, myogenin, and myf5 expression (Hinterberger et 
al., 1991). In addition, transactivation studies in muscle 
cell culture suggest that MRF4 can efficiently stimulate 
expression of the ~ subunit gene (Sunyer and Merlie, 
1993). A synergistic interaction between MRF4 (or some 
similarly regulated factor) and downstream effectors of a 
HRG-induced, tyrosine kinase-mediated signaling path- 
way may account for the postnatal, synapse-specific onset 
of ~ subunit gene expression. 
The postnatal decrease of the AChR 7 subunit gene 
expression that accompanies the rise in ~ expression 
might lead one to speculate that these processes are con- 
trolled by a single regulatory mechanism. The induction 
of the ~ subunit gene by HRG could occur in concert with 
a HRG-dependent decrease in expression of the 1, subunit 
gene. However, our previous findings (Martinou et al., 
1991) have shown no such reduction of y subunit mRNA 
accumulation by native ARIA; this result has been con- 
firmed using rHRG~11~_244 (G. C. C. and J. P. M., unpub- 
lished data). Thus, the 7 to ~ transition may reflect multiple 
regulatory mechanisms, such as the activity-dependent 
down-regulation of the ~, subunit gene and the postnatal 
appearance of an ~ subunit regulatory factor, rather than 
a single coordinated switch. 
Induction of Other Genes by HRG/ARIA 
A wide variety of proteins are found to be concentrated at 
the neuromuscular junction (for a list, see Hall and Sanes, 
1993). By in situ hybridization analysis, a small but growing 
number of genes encoding these proteins have been 
shown to exhibit synapse-specific or synapse-enriched ex- 
pression. In addition to the ~ subunit, these include the 
genes encoding the a, 13, ~', and (5 subunits of the AChR 
(Fontaine et al., 1988; Goldman and Staple, 1989). The 
gene encoding the membrane-associated a hesion mole- 
cule N-CAM and the AChR-associated cytoskeletal protein 
43K-rapsyn also exhibit mRNA concentration in synaptic 
muscle nuclei (Moscoso et al., 1995). Recently, the acetyl- 
cholinesterase gene has been shown to be synaptically 
expressed as well (Jasmin et al., 1993; Michel et al., 1994), 
and 7H4, an intriguing muscle-specific, noncoding RNA, 
shows synaptic enrichment in Northern analysis of dia- 
phragm mRNA (Velleca et al., 1994). It is tempting to 
speculate that this heterogeneous population of genes 
undergoes some degree of coordinate regulation by a 
nerve-derived factor, namely HRG/ARIA. In support of this 
hypothesis, the voltage-activated sodium channel, which 
exhibits aggregation at the base of synaptic junctional 
folds, has been shown in chicken myotube cultures to in- 
crease in abundance in response to ARIA (Corfas and 
Fischbach, 1993; Lupa et al., 1993). The presence of HRG/ 
ARIA in the brain and elsewhere suggests a far more 
global role of this factor in development. Indeed, the HRGs 
have been shown to restrict neural crest stem cells to a 
glial fate during early embryogenesis, or to promote 
astrocyte and oligodendrocyte maturation later in develop- 
ment (Pinkaskramarski et al., 1994; Shah et al., 1994; Var- 
tanian et al., 1994). Examination of HRG/ARIA-dependent 
gene expression at the neuromuscular junction may reveal 
a generalized signaling mechanism that could shed light 
on inductive events in the central nervous system. 
Experimental Procedures 
Reagents 
An 8 kDa peptide corresponding tothe EGF-like domain of HRGI31 
(residues 177-244)was recombinantiy expressed in E. coli and puri- 
fied as previously described (Holmes et al., 1992). EG F was purchased 
from Boehringer Mannheim. Nerve growth factor and fibroblast growth 
factor were kindly provided by E. M. Johnson, Jr. and D. M. Orntiz 
(Washington University School of Medicine), respectively. Recombi- 
nant C-terminal grin was a gift of J. T. Campanelli and R. H. Scheller 
(Ferns et al., 1993). The remaining factors and chemicals were ob- 
tained from Sigma. 
Immunohistochemistry 
Sheep antiserum was raised against rHRGI31, a bacterially expressed 
protein corresponding toamino acids 1-244 of HRGJ31. Affinity purifi- 
cation of antibody was performed by coupling rHRGI31~72~ to an 
AminoLink Plus column (Pierce). The coupled peptide was incubated 
in the presence of antiserum for 1 hr in phosphate-buffered saline 
(PBS). Following washes with PBS, bound antibody was eluted in the 
presence of 0.1 M glycine (pH 2.75), neutralized inTris-HCI (pH 9.0), 
and subsequently dialyzed in PBS. Bovine serum albumin (5 mg/ml) 
was added as a stabilizer. 
Sprague-Dawley rats were purchased from Harlan Sprague Daw- 
ley. Rats were anesthetized with methoxyfluorane or ketamine (8.7 
mg per 100 g) and xylazine (13 mg per 100 g) injected intraperitoneally. 
Light microscopic mmunohistochemical methods were performed as 
described (Covault and Sanes, 1986). In brief, cryostat sections of 
unfixed muscle were incubated with sheep antibody diluted in a solu- 
tion of bovine serum albumin in PBS (10 mg/ml) overnight at 4°C or 
for 3 hr at room temperature, washed, incubated with a fluorescein- 
conjugated rabbit anti-sheep secondary antibody (Boehringer Mann- 
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helm), and washed again. Sections were mounted and viewed with 
epifluorescence optics. To identify endptate regions, sections were 
doubly stained with rhodamine-~-bungarotoxin, which binds to AChRs 
in the postsynaptic membrane. To define muscle morphology, some 
sections were stained with crystal violet. 
Primary Muscle Cultures 
Myogenic cells were prepared essentially as described (Martinou et 
al., 1991). Cultures for RNA isolation were prepared from ICR mice 
(Harlan Spague Dawley) and plated at 5 x 106 cells per 6 cm dish or 
14.3 x 106 cells per 10 cm dish. Medium was renewed on day 2 after 
plating, and again on day 4, with the addition of cytosine arabino- 
nucleoside (araC; 5 I~M). On day 5, cultures were switched to DMEM 
containing 2% horse serum (differentiation media). In some plates, 
rHRG~l~77_244 (3 nM) or EGF (3 nM) was added. Cultures were har- 
vested for RNA 48 hr later. 
Cells for X-GAL histochemistry or o-nitrophenyl ~-D-galactopyrano- 
side (ONPG) solution assay were obtained from mice bearing the 
~3500nlacZ transgene (lines ~29 and s51; Sanes et al., 1991) and 
the s280nlacZ transgene (Gundersen et al., 1993). The mice used 
for the s3500nlacZ muscle cultures were the progeny of a male homo- 
zygous for the transgene and a wild-type female, such that each pup 
in the litter possessed the transgene. Cultures from both adult 
and newborn mice were analyzed, with equivalent results. For the 
~280nlacZ muscle culture, a male heterozygous for the transgene was 
mated to a wild-type female, resulting in a litter in which approximately 
50% of the newborn mice were transgenic. Transgenic cultures were 
typically plated at 2 x 106 cells per well of a 6 well dish. Cells were 
fed the following day and switched to differentiation media containing 
5 I~M araC on day 3 after plating, rHRG!31~77_244 (3 nM) or other test 
substances (Table 1) were added 1 day later. Myotubes were typically 
fed again on day 5 and assayed on day 7, but occasionally they were 
allowed to remain in culture up to day 10, with periodic media and 
rHRG~1~77_244 renewal. 
Sol 8 Culture and Transfection 
Sol 8 cells, a fusion-competent muscle cell line (Mulle et al., 1988), 
were maintained in log phase growth by trypsinization and replating 
in DMEM containing 20% fetal calf serum on gelatin-coated plates. 
For RNA isolation, these cells were allowed to reach confluence and 
were switched to differentiation media, rI-IRGI~I ~77-24, (3 nM) was added 
24 hr later, and myotube cultures were harvested 2 days afterward. 
For transient ransfection, Sol 8 cells were plated in 12 well tissue 
culture dishes at a density of 9 x 104 cells per well. The following day, 
cells were transfected using the low pH method of calcium phosphate 
transfection as described by Chen and Okayama (1987). For each 
well, 2.2 p.g of a plasmid construct and 0.4 ~g of the ~-galactosidase 
construct pEVl-lacZ were transfected. Approximately 18 hr after trans- 
fection, cells were washed with PBS and switched to differentiation 
media, rHRGI311~-244 (3 nM) was added directly to the wells the follow- 
ing day. Cultures were refed on day 3 after transfection and harvested 
on day 5. 
RNase Protection Assay 
Myotube RNA was isolated by the method of Chomczynski and Sacchi 
(1987) as modified by Xie and Rothblum (1991). RNA probe used to 
detect the AChR ~ transcript has been previously described (Martinou 
et al., 1991). Plasmid pBS5PEDlcL, a plasmid containing an 870 bp 
fragment from the mouse protein synthesis elongation factor Tu 
(eEFI~, accession #M22432), was used for detection of this mRNA 
species (Reddy et at., 1988). Probe synthesis and solution hybridiza- 
tions using 5-100 p.g of total RNA were performed as described (Mar- 
tinou and Merlie, 1991); for the eEFI(~ probe, hybridization proceeded 
at 57°C. Following RNase digestion and electrophoresis, gels were 
dried, exposed to film for visualization, and subjected to phosphorim- 
ager quantitation (Molecular Dynamics). 
Enzyme Assays 
To detect visually the ~-galactosidase product of the nlacZ reporter 
gene, cells from the transgenic muscle cultures were rinsed twice with 
PBS and fixed in 2% paraformaldehyde, 0.2% glutaraldehyde in PBS 
for 5 min. Cells were stained using X-GAL histochemistry procedures 
as described in Sanes et al. (1991). 
Enzymatic quantitation of 13-galactosidase activity' was performed 
using ONPG as the substrate. Cells were rinsed with PBS and har- 
vested with a rubber policeman. After low speed centrifugation, the 
cell pellet was resuspended in 0.25 M Tris-HCI (pH 8.0) and subjected 
to three rapid freeze-thaw cycles to lyse the cells. Cell lysate was 
incubated in 0.1 M sodium phosphate (pH 7.0) containing 0.64 mg! 
ml ONPG, 10 mM MgCI2, and 450 mM ~-mercaptoethanol until reaction 
was visibly yellow. Absorbance was measured at OD420. To quantitate 
endogenous levels of ~-galactosidase activity, muscle cultures from 
nontransgenic mice of the same genetic background (B6CBA F1 hy- 
brids) were treated in an identical fashion. 
CAT assays were performed as previously described (Gorman, 
1985) but with the following modifications: cells were lysed in 1 x 
Reporter Lysis Buffer (Promega) for 15 rain and subjected to centrifu- 
gation at 12,000 rpm for 10 rain. 13-Galactosidase activity (from the 
cotransfected pEVl-lacZ plasmid) was used to adjust for variations in 
transfection efficiency. Owing to a slight nonspecific (1.3-fold) effect 
of HRG on expression of the pEVl-lacZ plasmid, ~-galactosidase activ- 
ities from treated and untreated wells transfected with the same con- 
struct were averaged to facilitate comparisons within a given construct 
while normalizing for differences in transfection efficiency among con- 
structs. The CAT assay reaction buffer consisted of 0.25 M Tris-HCI 
(pH 8.0) containing 200 mg/ml bovine serum albumin. Following sepa- 
ration using thin-layer chromatography, the reaction products were 
subjected to phosphorimager quantitation. 
Plasmid Constructs 
Constructs ~280-, ~150-, and s150(mutE)-CAT have been described 
previously (Sunyer and Merlie, 1993). pSK-cardiac actin CAT contains 
a 245 bp EcoRI-Hindlll fragment of promoter sequence from the hu- 
man cardiac alpha actin gene upstream of the CAT reporter gene in 
the cloning vector pSKII+ (Miwa and Kedes, 1987). 
pEVl-lacZ, encoding the Rous sarcoma virus promoter fused to the 
bacterial lacZ gene, was used as a control to normalize for transfection 
efficiency in the Sol 8 muscle cell line (Pronin and Gautam, 1992). 
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